BRIEF-Gold Royalty Announces Acquisition Of Additional Borborema Royalty-March 2024-www.financetom.com

BRIEF-Gold Royalty Announces Acquisition Of Additional Borborema Royalty

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Gold Royalty Announces Acquisition Of Additional Borborema Royalty

Mar 11, 2026 12:39 AM

Jan 14 (Reuters) - ‌Gold Royalty Corp:

* ‍GOLD ⁠ROYALTY ⁠ANNOUNCES ‌ACQUISITION OF ⁠ADDITIONAL ‍BORBOREMA

ROYALTY

* GOLD ROYALTY CORP - ‍DEAL VALUED ‍AT US$45 MILLION INCLUDING

US$30

MILLION CASH

Source text:

Further company ‍coverage:

Previous page： SAP to Acquire Software Provider Reltio for Undisclosed Sum Next page： Nestle pushes ahead with about $5.75 billion Perrier and San Pellegrino deal, FT reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

SAP to Acquire Software Provider Reltio for Undisclosed Sum

Mar 27, 2026

08:44 AM EDT, 03/27/2026 (MT Newswires) -- SAP (SAP) has agreed to acquire Reltio, a master data management software provider, for an undisclosed sum, the companies said Friday. The acquisition will boost SAP's Business Data Cloud and accelerate its evolution to a fully interoperable enterprise data platform for agentic artificial intelligence, the companies said. The deal is expected to close...

Nestle pushes ahead with about $5.75 billion Perrier and San Pellegrino deal, FT reports

Mar 27, 2026

March 27 (Reuters) - Nestle's sale of a multibillion euro stake in its water business has moved forward, with private equity firms CD&R, KKR and PAI advancing to the next round of bidding for a 50% stake that could value the business at about 5 billion euros ($5.75 billion), the Financial Times reported on Friday. Platinum Equity has also expressed...

ARS Pharmaceuticals Says US FDA Approves Label Update Removing Age Restriction in Neffy Dose for Children

Mar 27, 2026

08:43 AM EDT, 03/27/2026 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said Friday that the US Food and Drug Administration has approved a label update for its needle-free neffy 1 mg treatment, removing the age requirement for pediatric patients. The company said the updated label allows use of neffy 1 mg in all patients weighing at least 33 lbs.,...

BRIEF-Eqt Real Estate Announces Sale Of 7 Million Square Foot Logistics Portfolio In Key Industrial Markets Across The U.S.

Mar 27, 2026

EQT AB: * EQT REAL ESTATE ANNOUNCES SALE OF 7 MILLION SQUARE FOOT LOGISTICS PORTFOLIO IN KEY INDUSTRIAL MARKETS ACROSS THE U.S. Source text: Further company coverage: ...